Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Phase II Study of GZR101 vs GZR33-70 in Type 2 Diabetes Mellitus
CTR20242263Phase 2Active
- Sponsor
- Gannex Pharma Co., Ltd.
- Start
- Jun 2024
- Modality
- Insulin and Analogs → Hormones & Growth Factors → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of GZR101 in type 2 diabetes mellitus (T2DM), sponsored by Gannex Pharma Co., Ltd.. Started Jun 2024; status: active.
02
Drugs
GZR101
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20242263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242263.